Solid Biosciences Inc. SLDB Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$56.74M-44.4% | -$49.79M-16.9% | -$45.78M-39.9% | -$39.48M-57.5% | -$39.28M-61.6% | ||
| $395K-2.9% | $467K-4.3% | $376K-7.2% | $386K-68.7% | $407K+24.5% | ||
| $5.15M+54.2% | $6.5M+70.1% | $3.93M+31.2% | $3.15M+50.3% | $3.34M+107% | ||
| $2.32M+403% | -$5.26M-745% | $3.7M+303% | $6K-99.4% | $461K+177% | ||
| -$473K-72.0% | $152K-90.6% | $2.2M-33.4% | $1.97M+618% | -$275K-229% | ||
| -$954K+52.8% | $7.65M— | —— | $4.08M— | -$2.02M-201% | ||
| $0-100% | $0-100% | $294K+1,236% | -$77K-450% | $22K0.0% | ||
| -$496K-19.2% | -$495K-19.6% | -$443K-11.3% | -$432K-10.5% | -$416K+12.1% | ||
| -$47.23M-48.3% | -$53.56M-80.7% | -$33.47M-41.2% | -$37.41M-74.3% | -$31.85M-26.4% | ||
| $165K+31.0% | $565K+177% | $85K+467% | $377K+31.8% | $126K-15.4% | ||
| $83.46M+27.7% | $23.92M+56.1% | $83.19M-2.7% | $63.44M+214% | $65.34M-21.6% | ||
| $44.76M+263% | —— | -$45.27M-312% | -$32.73M-532% | -$27.46M+28.6% | ||
| $0-100% | $203K+58.6% | $243K+102% | $142K-36.9% | $135K— | ||
| $18K— | —— | —— | $6K-33.3% | $0-100% | ||
| $239.03M+26.0% | $5.14M-25.9% | $1.18M-63.9% | $0-100% | $189.73M+76.9% | ||
| $236.56M+81.4% | -$1.4M-109% | -$77.57M-147% | -$71.75M— | $130.42M+199% | ||
| $0-100% | —— | —— | $60K-67.2% | $68K— | ||
| $619K+98.4% | $747K-7.0% | $327K-72.9% | $488K-53.1% | $312K-42.2% | ||
| -$1.65M0.0% | -$2.65M-156% | -$850K— | -$900K— | -$1.65M— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| -$473K-72.0% | $152K-90.6% | $2.2M-33.4% | $1.97M+618% | -$275K-229% | ||
| -$496K-19.2% | -$495K-19.6% | -$443K-11.3% | -$432K-10.5% | -$416K+12.1% | ||
| -$954K+52.8% | $7.65M— | —— | $4.08M— | -$2.02M-201% | ||
| $623K+8.3% | $611K+8.1% | $598K+2.2% | $587K+1.2% | $575K-13.0% | ||
| $0-100% | $0-100% | $294K+1,236% | -$77K-450% | $22K0.0% | ||
| -$128.38M-238% | -$71.5M-32.2% | -$38M+49.0% | -$31M-103% | -$38M+15.6% | ||
| $0-100% | —— | —— | $1.66M— | $20K— | ||
| $12.89M— | $0— | $0— | $0-100% | $0-100% | ||
| $0-100% | —— | —— | —— | $189.64M— | ||
| $239.97M— | —— | —— | $0— | $0-100% | ||
| $11.93M+4,748% | —— | $1.42M-54.2% | —— | $246K-92.0% | ||
| $0-100% | $203K+58.6% | $243K+102% | $142K-36.9% | $135K— | ||
| $25K-68.8% | —— | $329K+1,956% | -$80K— | $80K+300% | ||
| $7.5M+50.0% | —— | —— | —— | $5M— | ||
| -$496K-19.2% | -$495K-19.6% | -$443K-11.3% | -$432K-10.5% | -$416K+12.1% | ||
| —— | $0+100% | $0+100% | $0+100% | $0+100% | ||
| —— | $1.04M-2.1% | $1.04M-2.1% | $1.04M-2.1% | $1.04M-2.1% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| —— | $22.75K-80.6% | $22.75K-80.6% | $22.75K-80.6% | $22.75K-80.6% | ||
| —— | $180.75K+113% | $180.75K+113% | $180.75K+113% | $180.75K+113% | ||
| -$47.4M-48.2% | -$54.12M-81.3% | -$33.56M-41.5% | -$37.79M-73.7% | -$31.98M-26.2% | ||
| -$47.4M-48.2% | -$54.12M-81.3% | -$33.56M-41.5% | -$37.79M-73.7% | -$31.98M-26.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Solid Biosciences Inc. generate?
- Solid Biosciences Inc. (SLDB) generated -$171.7M in operating cash flow over the trailing twelve months.
- What is Solid Biosciences Inc.'s free cash flow?
- After $1.2M of capital expenditures, Solid Biosciences Inc.'s free cash flow was -$172.9M over the trailing twelve months, down 61.1% year over year.
- Where does Solid Biosciences Inc.'s cash flow data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
